Previous Article | Next Article 
Journal of Virology, December 2000, p. 11841-11848, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Persistent Rat Virus Infection in Smooth Muscle
of Euthymic and Athymic Rats
Robert O.
Jacoby,*
Elizabeth A.
Johnson,
Frank X.
Paturzo, and
Lisa
Ball-Goodrich
Section of Comparative Medicine, Yale University
School of Medicine, New Haven, Connecticut 06520-8016
Received 28 July 2000/Accepted 26 September 2000
 |
ABSTRACT |
Rat virus (RV) infection can cause disease or disrupt responses
that rely on cell proliferation. Therefore, persistent infection has
the potential to amplify RV interference with research. As a step
toward determining underlying mechanisms of persistence, we compared
acute and persistent RV infections in infant euthymic and athymic rats
inoculated oronasally with the University of Massachusetts strain of
RV. Rats were assessed by virus isolation, in situ hybridization, and
serology. Selected tissues also were analyzed by Southern blotting or
immunohistochemistry. Virus was widely disseminated during acute
infection in rats of both phenotypes, whereas vascular smooth
muscle cells (SMC) were the primary targets during persistent
infection. The prevalence of virus-positive cells remained
moderate to high in athymic rats through 8 weeks but decreased in
euthymic rats by 2 weeks, coincident with seroconversion and
perivascular infiltration of mononuclear cells.
Virus-positive pneumocytes and renal tubular epithelial
cells also were detected through 8 weeks, implying that kidney
and lung excrete virus during persistent infection. Viral mRNA
was detected in SMC of both phenotypes through 8 weeks, indicating that
persistent infection includes virus replication. However, only half of
the SMC containing viral mRNA at 4 weeks stained for
proliferating cell nuclear antigen, a protein expressed in cycling
cells. The results demonstrate that vasculotropism is a significant
feature of persistent infection, that virus replication continues
during persistent infection, and that host immunity reduces, but does
not eliminate, infection.
 |
INTRODUCTION |
Rat virus (RV) is a
common virus of laboratory rats and the prototype virus for the family
Parvoviridae (29, 35). It is one of three
parvovirus serotypes which infect rats; the others are H-1 virus
(54) and rat parvovirus (4). RV can disrupt research by causing disease or distorting biological responses in
laboratory rats (53). These effects have been attributed to
the proclivity of autonomous parvoviruses for mitotically active cells
(18). RV infection in fetal and infant rats, which have numerous cycling cells, can lead to severe tissue necrosis and clinical
morbidity (30, 34). The preference of RV for mitotically active cells is also thought to account for its ability to distort responses dependent on cell proliferation, including suppression of
tumor growth (7) and immune responses to transplantable neoplasms (13) and tissue alloantigens (40).
The risks to biomedical research from RV are heightened by the
persistence of infection after the onset of antiviral immunity. A
capacity for persistence was suspected from a early study of RV which
demonstrated infectious virus in immune rats (50). We
subsequently found that some rats inoculated with RV by the oronasal
route at 2 days of age harbored infection for at least 6 months and
excreted virus for up to 11 weeks, well after the onset of antiviral
immunity (32). Susceptibility to persistent infection
appeared to be age dependent, since randomly bred rats inoculated as
young adults with the Yale strain of RV (RV-Y) rarely remained infected
for more than 4 weeks unless they were immunodeficient (25,
32).
The adverse implications of persistent RV infection prompted a
search for causative factors. Preliminary studies of athymic rats
demonstrated that T-cell-mediated immunity is essential to eliminate
infection (25) and that humoral immunity alone suppresses but does not eliminate preexisting infection (23). These and other results (32) also indicated that mature tissues
contain cells susceptible to infection, but they did not confirm the
distribution or replication status of virus during persistent infection
or explore further the role of host immunity. Additionally, they emphasized that investigation of persistent infection required a more
reliable induction strategy. Although inoculation of 2-day-old euthymic
rats with RV-Y resulted in persistent infection, the prevalence varied
from 0 to 50% during 6 months of periodic sampling (32).
Furthermore, approximately one-third of the infants developed severe
clinical illness or died during acute infection. Inoculation of older
euthymic infants with RV-Y or decreasing the virus dose reduced
clinical morbidity but lowered the prevalence of persistent infection.
These drawbacks were overcome by inoculating 6-day-old infants with the
University of Massachusetts strain of RV (RV-UMass), a more virulent
strain (26). This regimen induced infection in 19 of 20 euthymic rats through 8 weeks postinoculation without producing
clinical signs and induced asymptomatic persistent infection consistently in athymic rats. Further, the results implied that the
influence of host immunity on the distribution and replication status
of virus could be investigated by comparing levels of persistent infection in rats of the two phenotypes. This paper reports initial results of that comparison for an 8-week interval after inoculation of
infant rats by a natural (oronasal) route. Smooth muscle cells (SMC)
were the most conspicuous sites of viral replication during persistent
infection in both phenotypes. The onset of immunity in euthymic rats
reduced but did not eliminate infection.
 |
MATERIALS AND METHODS |
Virus and virus isolation.
RV-UMass was obtained from Arthur
Like, University of Massachusetts School of Medicine, Worcester). Virus
stocks were prepared and quantified in NRK cells as previously
described (26).
Rats.
Pregnant Rowett rats, heterozygous at the
rnu locus (rnu/+), which had been mated with
athymic (rnu/rnu) males, were obtained from the Animal
Genetics and Production Branch, National Cancer Institute, Bethesda,
Md. Litters consisted of approximately equal numbers of
rnu/+ (euthymic) and rnu/rnu (athymic) pups. All
rats were housed in microisolette cages under barrier conditions
(25). Dams tested prior to inoculation did not have serum
antibodies to RV, rat parvovirus, rat coronaviruses, Sendai virus,
pneumonia virus of mice, Theiler's murine encephalomyelitis virus, or
Mycoplasma pulmonis. Sera collected at necropsy from rats
experimentally inoculated with RV were tested for antiviral antibodies
as described below. All positive sera had antibodies to RV but not to
the other rodent viruses. No clinical signs were detected during daily
observation of inoculated rats.
Unanesthetized 6-day-old rats were restrained manually and inoculated
oronasally by placing virus suspension containing a total of 100 50%
tissue culture infective doses in the nares (10 µl) and the mouth (10 µl). Suckling rats were weaned at approximately 3 weeks of age and
group housed by sex and genotype. Thirty-five euthymic rats and 33 athymic rats were inoculated with virus, and 5 rats of each genotype
were sham inoculated to serve as controls.
Tissue collection.
Tissues were collected from
virus-inoculated rats at 4, 6, 8, and 10 days and at 2, 4, and 8 weeks
after inoculation. The interval through week 2 was designated the acute
infection period because it included the preimmune and early immune
phases of infection. Results at weeks 4 and 8 represented persistent
infection, during which established antiviral immunity was detected by
serological testing in euthymic rats. Four to six rats of each genotype
were selected randomly at each time point and euthanized with carbon dioxide gas. Tissues collected for microscopic examination included lung, trachea, heart, great vessels, thymus, spleen, lymph nodes, salivary glands, liver, small intestine, pancreas, mesenteric and
genital vessels, kidney, testis, epididymus, ovaries, and uterus.
Tissues were immersed in periodate-lysine-paraformaldehyde (PLP)
(41) for 16 h, transferred briefly to
phosphate-buffered saline (PBS), embedded in paraffin wax, and
sectioned at a thickness of 5 µm preceding in situ hybridization
(ISH) and immunohistochemistry. The lungs were inflated with fixative
prior to immersion. Fresh pieces of lung, liver, spleen, and kidney
were flash frozen in liquid nitrogen and stored at
80°C prior to
extraction of nucleic acid. Fresh pieces of lung, kidney, and spleen
collected at 2, 4, and 8 weeks were explanted to detect infectious
virus. Blood samples were collected by cardiac puncture, and sera were
stored individually at
80°C prior to assay.
Explant culture.
Infectious virus was detected by explant
cultures that were prepared and evaluated as described previously
(45). Briefly, pieces of lung, spleen, and kidney were
collected aseptically at necropsy and minced into 2- to 3-mm fragments.
Seven to nine fragments of each tissue were cultured, by tissue, in
25-cm2 flasks for 3 weeks to permit significant cell
outgrowth. Cultures were then lysed by freezing and thawing and
inoculated into 324K cell monolayers for detection of cytopathic effect
and/or viral antigen.
Serology.
Sera from euthymic and athymic rats were tested
initially for antibodies to RV by an immunofluorescence assay
(51). Sera obtained from euthymic rats was tested
subsequently by enzyme-linked immunosorbent assay for RV antibodies
among immunoglobulin (Ig) classes M, G1, and G2a using bacterially
expressed RV VP2 (L. J. Ball-Goodrich, E. A. Johnson, and
R. O. Jacoby, submitted for publication) as the antigen. VP2 was
purified from the insoluble fraction using His-bind resin (Novagen,
Madison, Wis.). Ninety-six-well flat-bottom polystyrene microtiter
plates (Nunc MaxiSorp, Roskilde, Denmark) were coated with 150 ng of RV
VP2 or bacterially expressed
-galactosidase (
-Gal) protein
purified from the soluble fraction of bacteria as a negative control.
Plates were incubated at room temperature for 2 h and then
overnight at 4°C. Plates were washed three times with PBS containing
0.5% Tween 20 and blocked with 250 µl of 3% gelatin in PBS for
1 h at 37°C. Plates were washed again, and 100-µl samples of
serial dilutions of sera, in 0.5% bovine serum albumin (BSA)-PBS,
were added to antigen- and
-Gal-coated wells. Plates were incubated
at 37°C for 2 h and washed. Horseradish peroxidase
(HRP)-conjugated secondary antibodies, goat anti-rat Ig (IgG, IgA, and
IgM) used at a 1:10,000 dilution in PBS-0.5% BSA (ICN
Pharmaceuticals, Inc., Aurora, Ohio), or mouse anti-rat IgM, IgG1, or
IgG2a used at a 1:2,000 dilution in PBS-BSA (Serotec, Inc., Raleigh,
N.C.) was added to the appropriate wells and incubated at 37°C for
1 h. After the plates were washed three times,
3,3',5,5'-tetramethylbenzidine peroxidase substrate (Kirkergaard & Perry, Gaithersburg, Md.) was added to the wells for 5 min, followed by
addition of 1 N HCl to halt the reaction. Absorbance was measured in a
plate reader at 450 nm. Titer endpoints were defined as the inverse
dilution of the last absorbance value greater than the mean
-Gal
absorbance value plus 2 standard deviations for that dilution.
DNA extraction.
Small-molecular-weight DNA was extracted
from liver, kidney, spleen, and lung by a modified Hirt protocol
(27). Frozen tissue was pulverized in cold Teflon chambers
with stainless steel balls using a Dismembranator (Braun Instruments,
Allentown, Pa.). Powdered tissue was added to lysis buffer containing
0.7% sodium dodecyl sulfate (SDS), 1.25 M NaCl, 20 mM Tris (pH 8.0),
10 mM EDTA, and 250 µg of proteinase K per ml. Suspensions were
incubated at 37°C for 2 h, held overnight at 4°C, and then
centrifuged at 22,000 × g for 30 min to remove precipitated
chromatin. Low-molecular-weight DNA present in the supernate was
precipitated with ethanol, pelleted by centrifugation, and dried.
Samples were resuspended in Tris-EDTA containing 100 µg of RNase A
per ml and incubated at 37°C for 1 h, followed by
phenol-chloroform extraction and a second ethanol precipitation.
Southern analysis.
DNA samples were electrophoresed in 1%
agarose (SeaKem LE, Rockland, Maine), denatured, and transferred to a
Hybond N+ membrane (Amersham, Piscataway, N.J.) using standard
protocols. Membranes were baked for 2 h at 80°C. Blots were
hybridized at 42°C as described elsewhere (24) using a
randomly primed, 32P-labeled probe with a specific activity
of 1.2 × 109 cpm per µg of DNA. Blots were washed
twice for 30 min in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-0.2% SDS and then twice for 30 min in 0.2× SSC-0.2% SDS
and exposed to Kodak X-Omat AR film (Eastman Kodak, Rochester, N.Y.).
Molecular probes.
Randomly primed 32P-labeled
DNA probes were prepared using a commercial kit (New England Biolabs,
Beverly, Mass.) and purified RV-UMass DNA (nucleotides 1086 to 4300) as
a template. The same template was used to prepare biotinylated randomly
primed DNA probes to detect virus by immunoperoxidase staining
augmented by tyramine-based amplification (catalyzed reporter
deposition [CARD] probe) (NEN Life Science Products, Boston, Mass.)
(28).
Strand-specific 35S-labeled riboprobes (Promega, Madison,
Wis.) were used to differentiate cells containing viral mRNA, an
indicator of viral replication, from cells containing virion and RF
DNA. RV-UMass DNA from nucleotides 2655 to 4277 was cloned into
Bluescript II KS and SK vectors (Stratagene, La Jolla, Calif.). RNA
probes, detecting either plus-sense or minus-sense virus strand, were transcribed in equivalent amounts using the T7 promoter. The threshold for detection of RV virion DNA in PLP-fixed cells with the plus-sense probe was established previously as 2.3 × 104 copies
(Ball-Goodrich et al., submitted).
ISH.
Hybridization of tissue sections with randomly primed
or strand-specific radiolabeled probes was performed and assessed as previously described (24). Tissues were hybridized with the same probe batch and same exposure times to minimize animal-to-animal and tissue-to-tissue variation in autoradiography. Assessment of
radiolabeled hybridizations by light microscopy was based on a
semiquantitative scale. Signal prevalence was defined as high (greater
than 100 positive cells per tissue section), moderate (50 to 100 cells
positive per tissue section), low (5 to 50 positive cells per tissue
section), trace (1 to 5 positive cells per tissue section), or
negative. A cell was scored as positive if the overlying grain count
was at least 8 grains (twice background).
Tissue preparation for the CARD probe was identical to that for the
radiolabeled probe. The probe was denatured at 99°C for 4 min and
cooled, and 2 ng was added to 50 µl of hybridization mix containing
60% formamide, 10% dextran sulfate, 2× SSC, and 50 µg of salmon
sperm DNA per ml. Slides were coverslipped, immersed in mineral oil,
and incubated for 48 h at 42°C. Mineral oil was removed with
three washes in chloroform, and coverslips were removed during two 4×
SSC washes. Tissue sections were then washed twice in 60%
formamide-2× SSC at 42°C, twice with 2× SSC at 42°C, and once at
room temperature with PBS containing 0.05% Tween 20. Detection reactions were performed according to the manufacturer's protocols (Renaissance, TSA-Indirect; NEN Life Science Products).
Streptavidin-HRP was used at a dilution of 1:100 for both reactions,
and tissue was exposed to biotinylated tyramide for 10 min and to
4,4-diaminobenzidine for 15 min. Tissue sections were counterstained
with hematoxylin.
Immunohistochemistry for PCNA.
Paraffin sections were
dewaxed and hydrated. Endogeneous peroxidase activity was quenched by
incubation in 3% hydrogen peroxide. Tissue was incubated for 45 min at
37°C with a mouse monoclonal antibody against proliferating-cell
nuclear antigen (PCNA) linked to HRP by a flexible polymer backbone
which facilitates attachment of numerous HRP molecules (Dako
Corporation, Carpinteria, Calif.). After being washed in PBS, sections
were exposed to 4,4-diaminobenzidine for 4 min and counterstained with
hematoxylin. The sensitivity of PCNA staining was determined by
counting the fractions of PCNA-labeled cells in sections of liver from
two 4-week-old uninfected rats. Color photographs were taken of
randomly selected fields at a ×400 magnification, and 1,000 to 1,500 hepatocytes per animal were evaluated. Approximately 60% of
hepatocytes were scored as PCNA positive.
Colabeling for PCNA and viral mRNA.
Sections were first
labeled for PCNA by immunohistochemistry as described above. Then they
were hybridized for detection of viral mRNA using an
35S-labeled, minus-sense RNA probe containing 5 × 105 cpm/50 µl of hybridization solution. Slides were
washed as previously described and coated with autoradiographic
emulsion (24). Emulsion was developed after a 27- to 30-h
exposure to labeled tissue sections. One hundred thirteen cells
containing viral mRNA in tissues of persistently infected rats were
examined for coexpression of PCNA. Cells were scored as having strong,
weak, or no PCNA staining.
Immunohistochemistry for RV NS and VP2.
Immune serum for the
RV capsid protein (VP2) and the nonstructural protein (NS) was prepared
during a prior study of RV infection (Ball-Goodrich et al., submitted).
Selected tissues were stained by the avidin-biotin complex
immunoperoxidase method (30).
 |
RESULTS |
Clinical signs and gross lesions.
No clinical signs or gross
lesions were found with either phenotype.
Virus isolation.
Explant culture amplifies infectious RV in
tissue samples, so it is highly sensitive for detecting small
quantities of infectious virus encountered during persistent RV
infection (45). Lung, spleen, and kidney were assayed by
explant culture at weeks 2, 4, and 8. All rats of both phenotypes had
infectious virus through week 4, and all but one (a euthymic rat) were
virus positive at week 8 (Table 1).
Twenty-seven of 29 tissues (93%) from euthymic rats tested through
week 4 yielded infectious virus, but the prevalence decreased to 7 of
18 tissues (39%) by week 8. All tissue samples from athymic rats were
positive through week 8.
ISH with randomly primed probes.
A randomly primed,
32P-labeled DNA probe which detects a segment of the RV
genome encoding the NS and VP genes was used to estimate the
distribution and frequency of infected tissues and cells. It also
served to detect virus in tissues that were not conducive to explant
culture. A biotinylated CARD probe (28) was used to confirm
infected cell types.
The radiolabeled, randomly primed probe revealed that euthymic and
athymic rats developed widespread infection during the first 10 days
after inoculation, consistent with previous results (24).
Viral DNA was detected in thoracic and abdominal viscera by day 4, and
the prevalence in positive tissues, including lymph nodes and spleen,
was 100% on day 6 through week 2 (Table
2). Infected tissues contained few
necrotic cells, in contrast to the severe necrosis which typifies acute
infection in rats inoculated at 2 days of age. The frequency of
virus-positive tissues declined by week 8 and to a greater extent among
euthymic rats than athymic rats (Table 2).
The frequency of virus-positive cells in infected tissues was high in
euthymic and athymic rats through day 10 (Table
3). It decreased progressively in both
phenotypes from week 2 onward, but the decline was more pronounced in
euthymic rats. By week 8, tissues of euthymic rats still contained
positive cells, but in small numbers. All tissues examined in athymic
rats at week 8 had positive cells at low-to-moderate prevalence.
Blood vessels were common sites of acute and persistent infection in
both phenotypes. The aorta and pulmonary, mesenteric, renal, and
gonadal arteries, in addition to smaller arteries and arterioles within lung, liver, kidney, and other tissues, were involved. During acute infection, signal was prominent among
endothelial cells; however, it also was found in SMC within vessel
walls. During persistent infection, the number of positive endothelial cells decreased, leaving SMC as the primary targets. This finding was
confirmed using a biotinylated probe to examine tissues from two rats
of each genotype at weeks 4 and 8. Infected SMC occurred singly or in
groups and were distributed randomly or adjacent to the intima (Fig.
1A). Most SMC in affected vessels were
histologically normal; however, some had swollen, vacuolated, angular,
or pyknotic nuclei consistent with cell injury or impending death.
Intramural hemorrhage and inflammation was not detected, however, in
affected vessels. Virus-positive SMC also were found in the muscle
tunics of the small intestine, especially in athymic rats.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 1.
Tissues from rats inoculated oronasally with RV-UMass at
6 days of age and necropsied 4 weeks after inoculation. (A to C)
Tissues subjected to CARD ISH using a randomly primed RV probe; (D)
SMCs from an infected athymic rat stained for PCNA by
immunohistochemistry followed by ISH for RV using a minus-sense
35S-labeled RV riboprobe. (A) Branch of a mesenteric artery
from an athymic rat demonstrating RV DNA in SMC nuclei. Bar = 40 µm. (B) (Left) Lung from a euthymic rat with an infected pneumocyte.
Bar = 40 µm. (Right) Kidney from a euthymic rat with a infected
tubule epithelial cell. Bar = 40 µm. (C) Kidney from a euthymic
rat with an infected arteriole and perivascular infiltration by
mononuclear cells. Bar = 40 µm. (D) (Left) SMC in a gonadal
artery that is positive for RV mRNA and for PCNA. The plane of
focus was chosen to enhance visualization of overlying grains, so the
cell is slightly out of focus. Bar = 16 µm. (Right) Intestinal
SMC that is positive for RV mRNA and negative for PCNA. As with the
left image, the plane of focus was chosen to enhance visualization of
the overlying grains. Bar = 16 µm.
|
|
Lung was a site of persistent infection in rats of both phenotypes, and
pneumocytes were the most commonly affected cells (Fig. 1B [left]).
Respiratory epithelium also was infected in athymic rats. Renal tubular
epithelium was a common site of acute infection, and positive cells
were seen occasionally in rats of both phenotypes during
persistent infection (Fig. 1B [right]). A few positive biliary
epithelial cells and hepatocytes were found in the livers of
persistently infected athymic rats.
ISH with strand-specific riboprobes.
35S-labeled,
strand-specific riboprobes were used to detect the frequency and
distribution of cells containing RV DNA and RV mRNA. The
plus-sense probe was used to detect virion and
replicative-form DNA, and the minus-sense probe was used to detect
viral mRNA, indicative of active or recently completed
replication (8). Tissues from two rats of each phenotype
were examined at days 6, 8, and 10 and at week 2, and tissues from five
to six rats of each phenotype were examined at weeks 4 and 8. Hybridization with the plus-sense riboprobe detected a slightly lower
prevalence of positive cells compared to results using the randomly
primed probes, indicating some reduction in sensitivity (Tables
4 and 5).
This reduction was attributed largely to the lower energy and extent of
labeling of the single-stranded 35S riboprobe than was
observed with the double-stranded, randomly primed 32P
probe. The distribution of virus-positive cells was identical, however,
to that detected by the randomly primed probes.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Prevalence of RV-positive tissues during persistent
infection detected by ISH using strand-specific
35S-labeled riboprobesa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Mean prevalence of RV-positive cells during persistent
infection detected by ISH using strand-specific
35S-labeled riboprobesa
|
|
The prevalence of tissues and cells positive for viral DNA was
consistently higher in rats of both phenotypes than that for viral
mRNA. However, the prevalence of tissues and cells positive for
viral mRNA during persistent infection was higher in athymic rats
than in euthymic rats, except with peripheral (mesenteric) lymph nodes.
In athymic rats, mesenteric lymph nodes contained ample RV DNA,
especially in germinal centers, but no mRNA was detected.
Nevertheless, viral mRNA was found in other tissues of both
phenotypes through week 8. SMC in vessels and intestinal muscle tunics
were the most commonly affected cell types identified by both probes.
SMC also contained RV NS and VP antigens by immunoperoxidase staining
(data not shown). RV mRNA-positive cells in euthymic rats were
limited to renal and gonadal vessels by week 8 (Fig. 2), whereas vessels in many tissues of
athymic rats were positive at this time point.

View larger version (180K):
[in this window]
[in a new window]
|
FIG. 2.
Renal artery from a euthymic rat 8 weeks after
inoculation with RV-UMass. An SMC positive for RV mRNA is
identified (arrow). ISH with a minus-sense 35S-labeled RV
riboprobe is shown. Bar = 40 µm.
|
|
Colabeling for and PCNA and RV mRNA.
The replication
requirements of autonomous rodent parvoviruses, including utilization
of host cell DNA polymerase, imply that RV mRNA should be detected
primarily or solely in cycling cells. To test this expectation, tissues
were stained for PCNA by immunohistochemistry followed by ISH for RV
mRNA. PCNA is a highly stable protein which is first synthesized
during late G1, attains peak concentrations during S phase
of the cell cycle, and is not expressed during G0
(52). Staining for PCNA alone was performed in
preliminary experiments to determine whether infected
rats had more PCNA-positive cells than uninfected, age-matched control
rats. One thousand to 1,500 hepatocytes were counted in each of four
rats (one infected and one uninfected of each phenotype) 4 weeks after
inoculation. The fractions of PCNA-positive cells were approximately
equal in all livers: 54 and 59% in infected rats and 62 and 63% in
uninfected rats.
Mesenteric and gonadal vessels and small intestine from two infected
athymic rats at 4 weeks after inoculation were colabeled for PCNA and
viral mRNA. A total of 113 mRNA-positive cells were scored for PCNA staining (strong, weak, or negative) by two independent observers using light microscopy. The mean counts were negative (48%), weak (34%), and strong (18%). Therefore, approximately half of the mRNA-positive cells were scored as
negative for PCNA (Fig. 1D).
Southern analysis.
DNA was prepared from athymic and euthymic
rat tissues (spleen, kidney, liver, and lung) to enrich for
small-molecular-weight DNA. The band pattern observed during acute
infection (day 8) was similar to that established for RV-UMass
replication in synchronized tissue culture cells (Ball-Goodrich et al.,
submitted). It included minus-sense (virion), single-strand
DNA which migrates at approximately 2.5 kb and two double-stranded,
replicative forms which are approximately 5 kb (monomer) and 10 kb
(dimer) (Ball-Goodrich et al., submitted). All three forms also were
identified in athymic and euthymic tissues at weeks 4 and 8. However,
signal strength correlated with ISH results. Thus, bands were easily
visualized in athymic rats (Fig. 3), but
bands obtained from euthymic rats, although at the same location, were
too faint to photograph. The results provide further evidence, however,
that RV replicates during persistent infection.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 3.
Southern blot demonstrating replicative forms (RF) of RV
(monomer RF [mRF], dimer RF [dRF]) and single-strand DNA
(ssDNA) in representative tissues from persistently infected athymic
rats. Lanes 1 to 6 contain RV DNAs from two rats at week 4, and lanes 7 to 9 contain RV DNA from one athymic rat at week 8. Lanes 1, 4, and 7, kidneys; lanes 2, 5, and 8, livers; lanes 3, 6, and 9, lungs.
|
|
Antiviral immunity.
The decrease in virus-positive cells in
euthymic rats began with the onset of seroconversion. IgM antibody
against RV VP2 was detected by day 10, and IgG antibodies appeared by
day 14. IgM titers were not detected by week 4, whereas IgG titers
increased slowly (Table 6). The IgG
response consisted primarily of IgG2a, the titers for which were
consistently higher than for IgG1. IgG antibodies against RV NS
proteins also were detected by 14 days and were present through
week 8 (data not shown). Athymic rats developed weak anti-RV IgM
responses beginning at day 14 but did not develop anti-RV IgG.
View this table:
[in this window]
[in a new window]
|
TABLE 6.
Titers of RV antibody in euthymic rats determined by
enzyme-linked immunosorbent assay using RV VP2 as the antigen
|
|
Perivascular accumulations of mononuclear cells appeared in
tissues of euthymic rats by week 2, suggesting activation of
cell-mediated immunity. They occurred in hepatic portal triads,
adjacent to pulmonary vessels and mesenteric vessels, but were most
conspicuous surrounding renal cortical vessels, where they continued to
intensify through week 4 (Fig. 1C). Mononuclear cell infiltrates
were not a feature of early infection in athymic rats, but mild
perivasculitis developed among some renal and gonadal vessels and in a
few hepatic portal triads by week 4. Several athymic rats also had
developed mild bile duct hyperplasia.
 |
DISCUSSION |
Vasculotropism is an established feature of RV infection
(5, 17, 20, 30, 38) and one that it shares with numerous other viruses (22). For most of these viruses endothelium is the prominent target. However, some vasculotropic viruses, such as encephalomyocarditis virus (12), human and murine
herpesviruses (6, 42, 49, 56), and Seoul virus (R. O. Jacoby, S. R. Compton, F. X. Paturzo, and E. A. Johnson, unpublished data), have the capacity to infect SMC. A
few early reports noted acute RV infection of SMC using routine
histopathology (37, 38), and our prior ISH studies suggested
that SMC support RV during acute and persistent infection (24,
26). This paper confirms and extends those results by examining
persistent vascular infection with strand-specific probes and
immunohistochemistry. For both phenotypes, infection was more
prominent in SMC than in endothelium 4 and 8 weeks after inoculation
of virus. Infection included virus replication, since RV DNA,
mRNA, and NS and VP proteins were present in vascular (and
intestinal) SMC. The demonstration of RV replicative forms by Southern
analysis provided additional evidence that viral replication occurred
during persistent infection, and explant cultures confirmed the
presence of infectious virus in persistently infected kidney, lung, and
spleen. Detection of virus by ISH compared favorably with that by
explant culture. Minor discrepancies between the methods
indicate, however, the value of using complementary approaches to
detect small quantities of virus during persistent infection.
Virus-positive SMC were localized to subendothelial SMC or dispersed
throughout the muscle tunic. These patterns suggest that SMC infection
occurred by cell-to-cell extension from overlying endothelium or
through capillaries (vasa vasorum) which supply blood to the muscle
tunics. Although RV also may have reached the SMC by penetrating
between virus-damaged endothelial cells, possibly adherent to red blood
cells (47), the absence of intravascular hemorrhage makes
this pathway less likely.
The results of PCNA staining support previous evidence that SMC cycle
in young adult rats (16). Thus, these cells meet an important criterion for enabling RV replication. Furthermore, vascular
SMC in rats can proliferate in response to direct or endothelial injury
(14). Therefore, virus-induced endothelial injury and
subsequent infection of SMC may potentiate SMC turnover and promote
local RV infection. However, the pace of cell-to-cell infection
implicit to this possibility may be slow enough to mask increased cell
turnover in affected tissues.
The prevalence of viral-DNA-positive cells was consistently higher than
for viral-mRNA-positive cells during all stages of infection. Since
comparatively small amounts of mRNA are needed to initiate
parvoviral replication, this difference may indicate that RV mRNA
concentrations
which vary with the stage of virus replication
(Ball-Goodrich et al., submitted)
were below the level of ISH
detection in some infected cells. Additionally, one expects RV mRNA
to be more dispersed intracellularly than RV DNA, which is concentrated
in the nucleus and easier to detect by ISH. The lability of mRNA
compared to that of DNA also may have reduced detectable levels of RV
mRNA during the brief interval between euthanasia and tissue
fixation. Further, the comparatively higher frequency of RV
DNA-infected cells may reflect intracellular accumulation of
nonreplicating virus (i.e., virus sequestration), as has been hypothesized for persistent parvovirus infection of mink. Mori and
coworkers (44) found, in this regard, that viral DNA in lymph nodes was prevalent among germinal center cells resembling follicular dendritic cells or macrophages. The presence of RV DNA, but
not mRNA, in lymph node follicles of persistently infected athymic
rats resembles the results obtained with mink. This distribution may
represent sequestered RV and/or concentration of scavenged RV DNA from
persistent infection in other tissues.
Viral mRNA was detected in PCNA-positive and PCNA-negative SMC,
suggesting that RV replication can proceed in cells that are in the
G0 or early G1 phase of the cell cycle. A
report by Lenghaus and coworkers offers some precedent for this
possibility (36). They demonstrated replication of feline
parvovirus in cultured cells in which DNA synthesis was blocked by 6 mM
thymidine. Although the mechanism was not determined, they speculated
that a cell function blocked by thymidine may have been assumed by a
viral protein or that part of an infected cell's DNA-replicating
machinery was sufficient and available to support parvoviral
replication. Nevertheless, other explanations must be explored before
concluding that active RV replication occurs in cells that are not in S
phase. For example, cell death may not be the sole outcome of RV
replication during a single pass of infected SMC through the cell
cycle. If viral transcription or replication does not attain peak
levels in SMC prior to the end of S phase, it may be present when the cell returns to G0, an interval when PCNA is not expressed.
Technical deficiencies also must be considered to explain the variable
presence of PCNA in SMC containing RV mRNA. Inadequate sensitivity
of the immunostaining method for PCNA is an unlikely factor, since the
results were at least as sensitive as those reported previously for rat
tissues (19, 21). However, the intensity of PCNA staining
varies during the cell cycle (21), with weaker reactions
expected during G1 or early S phase. Therefore, small
amounts of PCNA may not have been detected by standard light microscopy. In this context, hybridization with the radiolabeled riboprobe may have quenched detection of PCNA, producing false-negative results. However, the fraction of PCNA-positive cells was approximately the same in tissues that were labeled for PCNA and mRNA as in those
stained only for PCNA. Furthermore, the ratios of cells which stained
strongly versus weakly for PCNA in the two groups of tissues were
similar. The lack of a definitive explanation for RV mRNA signal in
PCNA-negative SMC justifies closer examination of RV replication in
such cells. Infection of synchronized SMC in vitro, including staining
for cell cycle proteins less generic than PCNA, may clarify
whether RV replication can progress in noncycling cells.
The comparison between euthymic and athymic rats confirmed that the
intensity of persistent infection is strongly influenced by host
immunity. The reduction in the number of virus-infected cells after
seroconversion in euthymic rats is consistent with a role for humoral
immunity. However, the development of mononuclear cell infiltrates in
infected tissues in our study and in prior investigations (24,
30) and the prominence in this study of IgG2a responses,
consistent with a Th1 response in the rat (33), justify
exploration for cell-mediated responses. Weak IgM and mononuclear
responses occurred in the athymic rats. This result was not surprising
given the proclivity of athymic rats to develop some T cells as they
age (57). Additionally, athymic rats are capable of
producing IgM responses to thymus-independent antigens (60),
which may mean that RV has at least one epitope of this type.
The onset of immunity did not eliminate infection in euthymic rats but
may promote the sequestration of RV and/or reduce virus replication.
These possibilities are consistent with the results of passive
immunization, wherein RV immune serum, administered to infected
juvenile athymic rats, transiently suppressed detection of infectious
virus (23). Antiviral immunity also may reduce cell-associated expression of viral proteins, impeding effective immune
recognition of infected cells (1, 46). Alternatively, initial exposure to RV prior to immunologic maturity may result in
delayed elimination of virus due to suboptimal immune responses. Immunologic maturation in rats is not complete until at least 1 month
after birth (3, 43, 59, 61). Therefore, the 6-day-old rats
used in this study were probably immunologically immature when they
were inoculated. Additionally, RV may retard anti-RV immunity because
it is at least transiently immunosuppressive (40). We are
currently pursuing the influence of anti-RV immunity further by
determining responses to virus and viral proteins in adult rats.
Viral persistence is a feature of infection caused by other autonomous
parvoviruses (15, 48, 55, 58). Among these, the most
detailed pathogenesis studies have been performed with Aleutian disease
virus (ADV) (2, 9, 10, 39). Persistent RV and ADV infection
share the properties of low-level infection after the onset of host
immunity and a tropism for lymphoid tissue, but they differ in several
significant ways. For example, persistent ADV infection can be induced
in adult mink and encompasses viremia, plasmacytosis,
hypergammaglobulinemia, and immune complex disease, which reflect
elevated but functionally inadequate immune responsiveness. It is also
associated with reduced viral replication in individual cells.
Additionally, ADV does not target SMC during persistent infection.
Therefore, host and viral factors contributing to persistent RV and ADV
infection, while similar in some respects, also display potentially
important differences.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Section of
Comparative Medicine, Yale School of Medicine, P.O. Box 208016, New
Haven, CT 06520-8016. Phone: (203) 785-2525. Fax: (203) 785-7499. E-mail: robert.jacoby{at}yale.edu.
 |
REFERENCES |
| 1.
|
Ahmed, R.,
L. A. Morrison, and D. M. Knipe.
1996.
Persistence of viruses, p. 219-250.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lipincott-Raven, Philadelphia, Pa.
|
| 2.
|
Alexandersen, S.,
M. E. Bloom,
J. Wolfinbarger, and R. E. Race.
1987.
In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for virus replication in cell cultures and in mink kits with virus-induced interstitial pneumonia.
J. Virol.
61:2407-2419[Abstract/Free Full Text].
|
| 3.
|
Bakker, J. M.,
E. Broug-Holub,
H. Kroes,
E. P. van Rees,
G. Kraal, and J. F. van Iwaarden.
1998.
Functional immaturity of rat alveolar macrophages during postnatal development.
Immunology
94:304-309[CrossRef][Medline].
|
| 4.
|
Ball-Goodrich, L. J.,
S. E. Leland,
E. A. Johnson,
F. X. Paturzo, and R. O. Jacoby.
1998.
Rat parvovirus type 1: the prototype for a new rodent parvovirus serogroup.
J. Virol.
72:3289-3299[Abstract/Free Full Text].
|
| 5.
|
Baringer, J. R., and N. Nathanson.
1972.
Parvovirus hemorrhagic encephalopathy of rats: electron microscopic observations of the vascular lesions.
Lab. Investig.
27:514-522[Medline].
|
| 6.
|
Benditt, E. P.,
T. Barrett, and J. K. McDougall.
1983.
Viruses in the etiology of atherosclerosis.
Proc. Natl. Acad. Sci. USA
80:6386-6389[Abstract/Free Full Text].
|
| 7.
|
Bergs, V. V.
1969.
Rat virus-mediated suppression of leukemia induction by Moloney virus in rats.
Cancer Res.
29:1669-1672[Abstract/Free Full Text].
|
| 8.
|
Bloom, M. E.,
S. Alexandersen,
S. Mori, and J. B. Wolfinbarger.
1989.
Analysis of parvovirus infections using strand-specific hybridization probes.
Virus Res.
14:1-26[CrossRef][Medline].
|
| 9.
|
Bloom, M. E.,
H. Kanno,
S. Mori, and J. B. Wolfinbarger.
1994.
Aleutian mink disease: puzzles and paradigms.
Infect. Agents Dis.
3:279-301[Medline].
|
| 10.
|
Bloom, M. E.,
R. E. Race,
B. Aasted, and J. B. Wolfinbarger.
1985.
Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink.
J. Virol.
55:696-703[Abstract/Free Full Text].
|
| 11.
|
Brown, D. W.,
R. M. Welsh, and A. A. Like.
1993.
Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats.
J. Virol.
67:5873-5878[Abstract/Free Full Text].
|
| 12.
|
Burch, G. E., and J. M. Harb.
1993.
Encephalomyocarditis (EMC) virus infection of the mouse aorta: an ultrastructural study.
Am. Heart J.
86:669-675[CrossRef].
|
| 13.
|
Campbell, D. A.,
S. P. Staal,
E. K. Manders,
G. D. Bonnard,
R. K. Oldham,
R. K. Salzman, and R. B. Herberman.
1977.
Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidence that Kilham rat virus is responsible for the inhibitory effect.
Cell. Immunol.
33:378-391[CrossRef][Medline].
|
| 14.
|
Campbell, G. R.,
J. H. Campbell,
J. A. Manderson,
S. Horrigan, and R. E. Rennick.
1988.
Arterial smooth muscle. A multifunctional mesenchymal cell.
Arch. Pathol. Lab. Med.
112:977-986[Medline].
|
| 15.
|
Cherry, J. D.
1999.
Parvovirus infection in children and adults.
Adv. Pediatr.
46:245-269[Medline].
|
| 16.
|
Clowes, A. W.,
M. A. Reidy, and M. M. Clowes.
1983.
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.
Lab. Investig.
49:327-333[Medline].
|
| 17.
|
Cole, G. A.,
N. Nathanson, and H. Rivet.
1970.
Viral hemorrhagic encephalopathy of rats. II. Pathogenesis of central nervous system lesions.
Am. J. Epidemiol.
91:339-350[Abstract/Free Full Text].
|
| 18.
|
Cotmore, S. F., and P. Tattersall.
1987.
The autonomously replicating parvoviruses of vertebrates.
Adv. Virus Res.
33:91-174[Medline].
|
| 19.
|
Dietrich, D. R.,
R. Candrian,
D. S. Marsman,
J. A. Popp,
W. K. Kaufmann, and J. A. Swenberg.
1994.
Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine.
Cancer Lett.
79:45-51[CrossRef][Medline].
|
| 20.
|
El Dadah, A. H.,
N. Nathanson,
K. O. Smith,
R. A. Squire,
G. W. Santos, and E. C. Melby.
1967.
Viral hemorrhagic encephalopathy in rats.
Science
156:392-394[Abstract/Free Full Text].
|
| 21.
|
Foley, J. F.,
D. R. Dietrich,
J. A. Swenberg, and R. R. Maronpot.
1991.
Detection and evaluation of proliferating cell nuclear antigen (PCNA) in rat tissue by an improved immunohistochemical procedure.
J. Histotechnol.
14:237-241.
|
| 22.
|
Friedman, H. M.,
E. J. Macarak,
R. R. MacGregor,
J. Wolfe, and N. A. Kefalides.
1981.
Virus infection of endothelial cells.
J. Infect. Dis.
143:266-273[Medline].
|
| 23.
|
Gaertner, D. J.,
R. O. Jacoby,
E. A. Johnson,
F. X. Paturzo, and A. L. Smith.
1995.
Persistent rat virus infection in juvenile athymic rats and its modulation by antiserum.
Lab. Anim. Sci.
45:249-253[Medline].
|
| 24.
|
Gaertner, D. J.,
R. O. Jacoby,
E. A. Johnson,
F. X. Paturzo,
A. L. Smith, and J. L. Brandsma.
1993.
Characterization of acute rat parvovirus infection by in situ hybridization.
Virus Res.
28:1-18[CrossRef][Medline].
|
| 25.
|
Gaertner, D. J.,
R. O. Jacoby,
A. L. Smith,
R. B. Ardito, and F. X. Paturzo.
1989.
Persistence of rat virus in athymic rats.
Arch. Virol.
105:259-268[CrossRef][Medline].
|
| 26.
|
Gaertner, D. G.,
A. L. Smith, and R. O. Jacoby.
1996.
Efficient induction of persistent and prenatal infection with a parvovirus of rats.
Virus Res.
44:67-78[CrossRef][Medline].
|
| 27.
|
Hirt, B.
1967.
Selective extraction of polyoma DNA from infected mouse cell cultures.
J. Mol. Biol.
26:365-369[CrossRef][Medline].
|
| 28.
|
Hunyady, B.,
K. Krempels,
G. Harta, and E. Mazcy.
1996.
Immunohistochemical signal amplification by catalyzed receptor deposition and its application to double immunostainings.
J. Histochem. Cytochem.
44:1353-1362[Abstract].
|
| 29.
|
Jacoby, R. O., and L. J. Ball-Goodrich.
1995.
Parvovirus infections of mice and rats.
Semin. Virol.
6:329-337.
|
| 30.
|
Jacoby, R. O.,
P. N. Bhatt,
D. J. Gaertner,
A. L. Smith, and E. A. Johnson.
1987.
The pathogenesis of rat virus infection in infant and juvenile rats after oronasal inoculation.
Arch. Virol.
95:251-270[CrossRef][Medline].
|
| 31.
|
Jacoby, R. O.,
E. A. Johnson,
L. Ball-Goodrich,
A. L. Smith, and M. D. McKisic.
1995.
Characterization of mouse parvovirus infection by in situ hybridization.
J. Virol.
69:3915-3919[Abstract].
|
| 32.
|
Jacoby, R. O.,
E. A. Johnson,
F. X. Paturzo,
D. J. Gaertner,
J. L. Brandsma, and A. L. Smith.
1991.
Persistent rat parvovirus infection in individually housed rats.
Arch. Virol.
117:193-205[CrossRef][Medline].
|
| 33.
|
Kawai, T.,
R. Eisen-Lev,
M. Seki,
J. W. Eastcott,
M. E. Wilson, and M. A. Taubman.
2000.
Requirement of B7 co-stimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease.
J. Immunol.
164:2102-2109[Abstract/Free Full Text].
|
| 34.
|
Kilham, L., and G. Margolis.
1966.
Spontaneous hepatitis and cerebellar hypoplasia in suckling rats due to congenital infection with rat virus.
Am. J. Pathol.
49:457-475[Medline].
|
| 35.
|
Kilham, L., and L. Olivier.
1959.
A latent virus of rats isolated in tissue culture.
Virology
7:428-437[CrossRef][Medline].
|
| 36.
|
Lenghaus, C.,
T. K. Mun, and M. J. Studdert.
1985.
Feline panleukopenia virus replicates in cells in which cellular DNA synthesis is blocked.
J. Virol.
53:345-349[Abstract/Free Full Text].
|
| 37.
|
Lipton, H. L., and R. T. Johnson.
1972.
The pathogenesis of rat virus infections in the newborn hamster.
Lab. Investig.
27:508-513[Medline].
|
| 38.
|
Margolis, G., and L. Kilham.
1970.
Parvovirus infections, vascular endothelium and hemorrhagic encephalopathy.
Lab. Investig.
22:478-488[Medline].
|
| 39.
|
McKenna, R.,
N. H. Olsen,
P. R. Chipman,
T. S. Baker,
T. F. Booth,
J. Christensen,
B. Aasted,
J. N. Fox,
M. E. Bloom,
J. B. Wolfinbarger, and M. Agbandje-McKenna.
1999.
Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity.
J. Virol.
73:6882-6891[Abstract/Free Full Text].
|
| 40.
|
McKisic, M. D.,
F. X. Paturzo,
D. J. Gaertner,
R. O. Jacoby, and A. L. Smith.
1995.
A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions.
J. Immunol.
155:3979-3986[Abstract].
|
| 41.
|
McLean, I. W., and P. K. Nakane.
1974.
Periodiate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy.
J. Histochem. Cytochem.
22:1077-1183[Abstract].
|
| 42.
|
Melnick, J. L.,
G. R. Dreesman,
C. H. McCollum,
B. L. Petrie,
J. Burek, and M. E. DeBakey.
1983.
Cytomegalovirus antigen within human arterial smooth muscle cells.
Lancet
II:644-647[CrossRef].
|
| 43.
|
Middleton, P. A., and W. W. Bullock.
1984.
Ontogeny of T-cell mitogen response in Lewis rats: I. Culture conditions and developmental patterns.
Dev. Comp. Immunol.
8:895-906[CrossRef][Medline].
|
| 44.
|
Mori, S.,
J. B. Wolfinbarger,
M. Miyazawa, and M. E. Bloom.
1990.
Replication of Aleutian disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages.
J. Virol.
65:952-956.
|
| 45.
|
Paturzo, F. X.,
R. O. Jacoby,
P. N. Bhatt,
A. L. Smith,
D. G. Gaertner, and R. B. Ardito.
1987.
Persistence of rat virus in seropositive rats as detected by explant culture.
Arch. Virol.
95:137-142[CrossRef][Medline].
|
| 46.
| Ploegh, H. Viral strategies of immune evasion.
Science 280:248-253.
|
| 47.
|
Portella, O. B.
1963.
Hemadsorption and related studies on the hamster-osteolytic viruses.
Arch. Gesamte Virusforsch.
14:277-305[CrossRef].
|
| 48.
|
Porter, D. D.,
A. E. Larsen, and H. G. Porter.
1980.
Aleutian disease of mink.
Adv. Immunol.
29:261-286[Medline].
|
| 49.
|
Presti, R. M.,
J. L. Pollock,
A. J. Dal Canto,
A. K. O'Guin, and H. W. Virgin.
1998.
Interferon regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.
J. Exp. Med.
188:577-588[Abstract/Free Full Text].
|
| 50.
|
Robey, R. E.,
D. R. Woodman, and F. M. Hetrick.
1968.
Studies on the natural infection of rats with the Kilham rat virus.
Am. J. Epidemiol.
88:139-143[Abstract/Free Full Text].
|
| 51.
|
Smith, A. L.
1983.
Response of weanling randombred mice to inoculation with minute virus of mice.
Lab. Anim. Sci.
33:37-39[Medline].
|
| 52.
|
Takasaki, Y.,
J. S. Deng, and E. M. Tan.
1981.
A nuclear antigen associated with cell proliferation and blast transformation. Its distribution in synchronized cells.
J. Exp. Med.
154:1899-1909[Abstract/Free Full Text].
|
| 53.
|
Tattersall, P., and S. F. Cotmore.
1986.
The rodent parvoviruses, p. 305-348.
In
P. N. Bhatt, R. O. Jacoby, H. C. Morse, and A. E. New (ed.), Viral and mycoplasmal infections of rodents: effects on biomedical research. Academic Press, Orlando, Fla.
|
| 54.
|
Toolan, H. W.,
G. Dalldorf,
M. Barclay,
S. Chandra, and A. E. Moore.
1960.
An unidentified filterable agent isolated from transplanted human tumors.
Proc. Natl. Acad. Sci. USA
46:1256-1259[Free Full Text].
|
| 55.
|
Truyen, U., and C. R. Parrish.
2000.
Epidemiology and pathology of autonomous parvoviruses.
Contrib. Microbiol.
4:149-162[Medline].
|
| 56.
|
Tumilowicz, J. J.,
M. E. Gawlick,
P. P. Bowell, and J. J. Trentin.
1985.
Replication of cytomegalovirus in human arterial smooth muscle cells.
J. Virol.
56:839-845[Abstract/Free Full Text].
|
| 57.
|
Vaessen, L. M. B.,
R. Broekhuizen,
J. Rozing,
J. G. Vos, and H.-J. Schuurman.
1986.
T-cell development during ageing in the congenitally athymic (nude) rat.
Scand. J. Immunol.
24:223-235[CrossRef][Medline].
|
| 58.
|
van Elsacker-Niele, A. M., and A. C. Kroes.
1999.
Human parvovirus B19: relevance in internal medicine.
Neth. J. Med.
54:221-230[CrossRef][Medline].
|
| 59.
|
Veerman, A. J.
1975.
The postnatal development of the white pulp in the rat spleen and the onset of immunocompetence against a thymus-independent antigen.
Z. Immunitatsforsch. Exp. Klin. Immunol.
150:45-49[Medline].
|
| 60.
|
Vos, J. G.,
J. Buys,
P. Beekhof, and A. M. Hagenaars.
1979.
Quantification of total IgM and IgG and specific IgM and IgG to a thymus-independent (LPS) and a thymus-dependent (tetanus toxoid) antigen in the rat by enzyme-linked immunosorbent assay (ELISA).
Ann. N. Y. Acad. Sci.
320:518-534[Abstract].
|
| 61.
|
Vujanovic, N. L.,
R. B. Herberman, and J. C. Hiserodt.
1988.
Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny and target specificity.
Cancer Res.
48:878-883[Abstract/Free Full Text].
|
Journal of Virology, December 2000, p. 11841-11848, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shackelton, L. A., Hoelzer, K., Parrish, C. R., Holmes, E. C.
(2007). Comparative analysis reveals frequent recombination in the parvoviruses. J. Gen. Virol.
88: 3294-3301
[Abstract]
[Full Text]
-
Ball-Goodrich, L. J., Paturzo, F. X., Johnson, E. A., Steger, K., Jacoby, R. O.
(2002). Immune Responses to the Major Capsid Protein during Parvovirus Infection of Rats. J. Virol.
76: 10044-10049
[Abstract]
[Full Text]
-
Ball-Goodrich, L. J., Johnson, E., Jacoby, R.
(2001). Divergent replication kinetics of two phenotypically different parvoviruses of rats. J. Gen. Virol.
82: 537-546
[Abstract]
[Full Text]